Sortilin and lipoprotein metabolism: Making sense out of complexity

Current Opinion in Lipidology

Volumn 25, Issue 5, 2014, Pages 350-357

  Strong, Alanna ^a   Patel, Kevin ^a   Rader, Daniel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherosclerotic cardiovascular disease; Genome wide association study; Lipid metabolism; Low density lipoprotein cholesterol; Sort1

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA GALACTOSIDASE; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CELL SURFACE RECEPTOR; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SORTILIN; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1P; ENDOPLASMIC RETICULUM STRESS; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ATHEROSCLEROSIS; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; RISK FACTOR;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ATHEROSCLEROSIS; CHOLESTEROL, LDL; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84921438155     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000110     Document Type: Review

References (50)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121: 948-954.
2. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
3. Hobbs H, Rader DJ. Lipoprotein metabolism. In: Kasper D, Braunwald E, Fauci AS, editors. Harrison's principles of internal medicine. New York: Mc Graw Hill Publishers; 2007. pp. 2416-2429.
4. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40: 189-197.
5. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169.
6. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009; 41: 56-65.
7. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713.
8. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453.
9. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43: 333-338.
10. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466: 714-719.
11. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2010; 208: 183-189.
12. Strong A. Sortilin as a novel regulator of plasma cholesterol, very-low density lipoprotein secretion and LDL catabolism. In: Cellular and molecular biology. Philadelphia: University of Pennsylvania; 2012.
13. Strong A, Ding Q, Edmondson AC, et al. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. J Clin Invest 2012; 122: 2807-2816.
14. Ai D, Baez JM, Jiang H, et al. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest 2012; 122: 1677-1687.
15. Bi L, Chiang JY, Ding WX, et al. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res 2013; 54: 2754-2762.
16. Tveten K, Strom TB, Cameron J, et al. Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia. Atherosclerosis 2012; 225: 370-375.
17. Ding Q, Lee YK, Schaefer EA, et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 2013; 12: 238-251.
18. Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 2010; 12: 213-223.
19. Nielsen MS, Madsen P, Christensen EI, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 2001; 20: 2180-2190.
20. Petersen CM, Nielsen MS, Nykjaer A, et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 1997; 272: 3599-3605.
21. Morris NJ, Ross SA, Lane WS, et al. Sortilin is the major 110-kDa protein in GLUT4 vesicles from adipocytes. J Biol Chem 1998; 273: 3582-3587.
22. Canuel M, Korkidakis A, Konnyu K, Morales CR. Sortilin mediates the lysosomal targeting of cathepsins D and H. Biochem Biophys Res Commun 2008; 373: 292-297.
23. Lefrancois S, Zeng J, Hassan AJ, et al. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J 2003; 22: 6430-6437.
24. Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427: 843-848.
25. Arnett MG, Ryals JM, Wright DE. Pro-NGF, sortilin, and p75NTR: Potential mediators of injury-induced apoptosis in the mouse dorsal root ganglion. Brain Res 2007; 1183: 32-42.
26. Hu F, Padukkavidana T, Vaegter CB, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010; 68: 654-667.
27. Carlo AS, Gustafsen C, Mastrobuoni G, et al. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-beta peptide in the brain. J Neurosci 2013; 33: 358-370.
28. Prabakaran T, Nielsen R, Satchell SC, et al. Mannose 6-phosphate receptor and sortilin mediated endocytosis of alpha-galactosidase A in kidney endothelial cells. PLoS One 2012; 7: E39975.
29. Evans SF, Irmady K, Ostrow K, et al. Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J Biol Chem 2011; 286: 29556-29567.
30. Nielsen MS, Jacobsen C, Olivecrona G, et al. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999; 274: 8832-8836.
31. Klingenberg R, Gerdes N, Badeau RM, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013; 123: 1323-1334.
32. Chamberlain JM, O'Dell C, Sparks CE, Sparks JD. Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting. Biochem Biophys Res Commun 2013; 430: 66-71.
33. Karki S, Chakrabarti P, Huang G, et al. The multilevel action of fatty acids on adiponectin production by fat cells. PLoS One 2011; 6: E28146.
34. Kwon S, Christian JL. Sortilin associates with transforming growth factor-beta family proteins to enhance lysosome-mediated degradation. J Biol Chem 2011; 286: 21876-21885.
35. Gelling CL, Dawes IW, Perlmutter DH, et al. The endosomal protein-sorting receptor sortilin has a role in trafficking alpha-1 antitrypsin. Genetics 2012; 192: 889-903.
36. Zhou B, Zhuang J, Gu D, et al. WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. J Am Soc Nephrol 2010; 21: 82-92.
37. Jun JY, Ma Z, Pyla R, Segar L, et al. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita): ApoE(-/-) mice. Atherosclerosis 2012; 225: 341-347.
38. Dube JB, Johansen CT, Hegele RA. Sortilin: An unusual suspect in cholesterol metabolism: FromGWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. Bioessays 2011; 33: 430-437.
39. Willnow TE, Kjolby M, Nykjaer A. Sortilins: New players in lipoprotein metabolism. Curr Opin Lipidol 2011; 22: 79-85.
40. Tall AR, Ai D. Sorting out sortilin. Circ Res 2011; 108: 158-160.
41. Coutinho MF, Bourbon M, Prata MJ, Alves S. Sortilin and the risk of cardiovascular disease. Rev Port Cardiol 2013; 32: 793-799.
42. Kim T, Hempstead BL. NRH2 is a trafficking switch to regulate sortilin localization and permit proneurotrophin-induced cell death. EMBO J 2009; 28: 1612-1623.
43. Ozcan L, Tabas I. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu Rev Med 2012; 63: 317-328.
44. Wang X, Shao Z, Zetoune FS, et al. NRADD, a novel membrane protein with a death domain involved in mediating apoptosis in response to ER stress. Cell Death Differ 2003; 10: 580-591.
45. Reinhardt S, Schuck F, Grosgen S, et al. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. FASEB J 2014; 28: 978-997.
46. Gustafsen C, Kjolby M, NyegaardM, et al. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. Cell Metab 2014; 19: 310-318.
47. Mendoza-Barbera E, Julve J, Nilsson SK, et al. Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. J Lipid Res 2013; 54: 649-661.
48. Campagnolo L, Costanza G, Francesconi A, et al. Sortilin expression is essential for pro-nerve growth factor-induced apoptosis of rat vascular smooth muscle cells. PLoS One 2014; 9: E84969.
49. JonesGT, Bown MJ, Gretarsdottir S, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet 2013; 22: 2941-2947.
50. Claudia GMA, Singh S, Shibasaki M, Aikawa E. Sortilin 1 is a novel inducer of vascular calcification via a phosphate-dependent mechanism. In: American Heart Association. Los Angeles, California: American Heart Association; 2012.